The independent, kidney-based medical device company will be called NewCo and be equally owned by the Dublin, Ireland-based healthcare tech firm and the kidney care provider headquartered in Denver.
“This is an exciting moment that will shape the future of kidney care,” Ven Manda, president of rental care solutions for Medtronic and NewCo’s future CEO, said in a May 26 news release.
The companies said the new venture will improve the treatment experience and patient outcomes at a time when the number of people with kidney failure is expected to double, exceeding 6 million in the next decade. Treatments will include home-based dialysis and other products.
The deal is expected to close next year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
